Showing results (811-820 of 1,839) with videos related to

Sort By:
Pageof 184
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
ESMO Open|September 10, 2024
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trialM Vaz Batista, J M Pérez-García, P Cortez, et al.
ESMO Open|September 10, 2024
Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinomaH Cheng, J Chen, G Jia, et al.
ESMO Open|March 7, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancerL W de Boo, K Jóźwiak, N D Ter Hoeve, et al.
ESMO Open|March 8, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancerK Shitara, T Fleitas, H Kawakami, et al.
ESMO Open|February 23, 2024
Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)R Berardi, F Rossi, R Papa, et al.
ESMO Open|February 24, 2024
Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancerM Bottosso, F Mosele, S Michiels, et al.
ESMO Open|February 13, 2024
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphomaY M Geurts, S I M Neppelenbroek, B M P Aleman, et al.
ESMO Open|November 18, 2023
Time toxicity associated with early phase clinical trial participationU Nindra, G Shivasabesan, S Childs, et al.
ESMO Open|November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practiceP Grivas, E Grande, I D Davis, et al.
Pageof 184